DUBLIN, Nov. 3, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Peptide Therapeutics Market 2014-2018" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
Peptides are amino acids sequences and among the most potent biologically active substances found in nature. Peptides are used to control, trigger, and maintain physiological processes in living beings. However, the use of peptides as therapeutic agents has always been difficult because of their inherent instability and incapability to cross cellular membranes.
Peptides also entail the requirement of specific technology to tackle the extensive and challenging steps in their synthesis. Currently, there are more than 80 peptides marketed by various companies. These companies explore the probability of designing and engineering peptides that overcome their natural confines and allow these potent chemical entities to be used as therapeutic agents.
The analysts forecast the Global Peptide Therapeutics market to grow at a CAGR of 9.25 percent over the period 2013-2018.
This report covers the present scenario and the growth prospects of the Global Peptide Therapeutics market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various approved peptide drugs to treat individuals against various diseases, such as, cardiovascular, metabolic, neurological, respiratory, and others.
The report, the Global Peptide Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Peptide Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
One key trend upcoming in the market is the growing popularity of peptide therapeutics in the market, which results in increased consumption of peptide drugs, thereby affecting market growth.
According to the report, the major driving factor of this market is the increase in patient populations suffering from various diseases in many countries. This causes an increase in the consumption of peptide medicines, thereby boosting market growth.
Further, the report states that the high cost of therapy is a major challenge to the growth of the market. It results in a decrease in the rate of patients seeking treatment in the market, which restrains the growth.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Market Segmentation by Route of Administration
08. Market Segmentation by Drug Class
09. Market Segmentation by Technology
10. Geographical Segmentation
11. Peptide Synthesis
12. Optimization of Peptides
13. Stabilization of Peptides
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
22. Pipeline Portfolio
23. Key Vendor Analysis
24. Other Reports in this Series
Companies Mentioned:
- Abbvie
- Advanced Accelerator Applications
- Akashi Therapeutics
- Amylin
- Anthera Pharmaceuticals
- AstraZeneca
- AstraZeneca
- Bachem
- Bristol Myers Squibb
- Cardiorentis
- Cubist Pharmaceuticals
- Debiopharm
- Derma Sciences
- Diartis Pharmaceuticals
- Eli Lilly
- GlaxoSmithKline
- Hanmi Pharmaceutical
- Insmed
- Ipsen
- Johnson & Johnson
- Lonza
- Mallinckrodt
- Merck
- MolMed
- Novartis
- Novo Nordisk
- Nymox Pharmaceutical
- Par Pharmaceuticals
- PeptiDream
- Peptisyntha
- Polypeptide Group
- Radius Health
- Repligen
- Sanofi
- SciClone
- Shire
- Takeda Pharmaceutical
- The Medicines Company
- Transition Therapeutics
- X-Gen Pharmaceuticals
- Zealand Pharma
- Zydus Cadila
For more information visit http://www.researchandmarkets.com/research/lzd9j2/global_peptide
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
